| 607898 |
BMJ OPEN |
Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol |
2020-11-01 |
10.1136/bmjopen-2020-040527 |
Greenland Julia C, Cutting Emma, Kadyan Sonakshi, Bond Simon, Chhabra Anita, Williams-Gray Caroline H |
| 607897 |
BMJ OPEN |
Mapping mental health recovery tools developed by mental health service users and ex-users: protocol for a scoping review |
2020-11-01 |
10.1136/bmjopen-2020-043957 |
Sampietro Hernán María, Carmona Viviana R, Rojo J Emilio, Gómez-Benito Juana |
| 607896 |
BIOMOLECULES & THERAPEUTICS |
Inhibition of LPA5 Activity Provides Long-Term Neuroprotection in Mice with Brain Ischemic Stroke |
2020-11-01 |
10.4062/biomolther.2020.159 |
Sapkota, Arjun, Park, Sung Jean, Choi, Ji Woong |
| 607895 |
CANCER MANAGEMENT AND RESEARCH |
Antitumor Efficacy of Oncolytic Herpes Virus Type 1 Armed with GM-CSF in Murine Uveal Melanoma Xenografts |
2020-11-01 |
10.2147/cmar.s274605 |
Liu Sisi, Liu Fusheng, Zhao Mingwei, Zhang Junwen |
| 607894 |
大韓保健硏究 |
지역사회획득 폐렴환자의 연령별 사망 위험도 변화 |
2020-11-01 |
10.22900/kphr.2020.46.4.006 |
안미선, 이재빈, 우혜경 |
| 607893 |
NEURO-ONCOLOGY |
IMMU-50. BBB CROSSING NANO-IMMUNOMEDICINE COMBINATION THERAPY TO TREAT BRAIN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | IMMU-50. BBB CROSSING NANO-IMMUNOMEDICINE COMBINATION THERAPY TO TREAT BRAIN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA |
2020-11-01 |
10.1093/neuonc/noaa215.480 |
Sun Tao, Yang Jiyuan, Gamburg Maximilian, Ljubimov Vladimir, Grodzinski Zachary, Black Keith, Holler Eggehard, Kopeček Jindřich, Ljubimova Julia |
| 607892 |
NEURO-ONCOLOGY |
DDRE-09. DEVELOPING IDO-PROTACS TO IMPROVE IMMUNOTHERAPEUTIC EFFICACY IN PATIENTS WITH GLIOBLASTOMA | DDRE-09. DEVELOPING IDO-PROTACS TO IMPROVE IMMUNOTHERAPEUTIC EFFICACY IN PATIENTS WITH GLIOBLASTOMA |
2020-11-01 |
10.1093/neuonc/noaa215.254 |
Bollu Lakshmi, Wainwright Derek, Zhai Lijie, Ladomersky Erik, Lauing Kristen, Bell April, Schlitz Gary |
| 607891 |
NEURO-ONCOLOGY |
TMOD-25. IN VIVO MODEL OF TREATMENT-RESISTANT GLIOBLASTOMA HIGHLIGHTS SEX DIFFERENCES IN SURVIVAL | TMOD-25. IN VIVO MODEL OF TREATMENT-RESISTANT GLIOBLASTOMA HIGHLIGHTS SEX DIFFERENCES IN SURVIVAL |
2020-11-01 |
10.1093/neuonc/noaa215.975 |
Al-Gizawiy Mona, Wujek Robert, Prah Melissa, Molino Salvatore, Chitambar Christopher, Schmainda Kathleen |
| 607890 |
NEURO-ONCOLOGY |
DDRE-27. LMNA-PRKDC AXIS PROMOTES CHEMORESISTANCE IN RECURRENT GBM BY STABILIZING DNA REPAIR FOCI | DDRE-27. LMNA-PRKDC AXIS PROMOTES CHEMORESISTANCE IN RECURRENT GBM BY STABILIZING DNA REPAIR FOCI |
2020-11-01 |
10.1093/neuonc/noaa215.272 |
Saathoff Miranda, Shireman Jack, Savchuk Sol, Baisiwala Shivani, Park Cheol, James Charles, Ahmed Atique |
| 607889 |
GYNECOLOGIC ONCOLOGY REPORTS |
Potential alternative progestin therapy for low-grade endometrial stromal sarcoma: A case report |
2020-11-01 |
10.1016/j.gore.2020.100634 |
Maenohara Shoji, Fujimoto Takahiro, Okadome Masao, Sonoda Kenzo, Taguchi Kenichi, Saito Toshiaki |
